Divestment and Strategic Shift

Sigma Advanced Systems Limited has completed the sale of its stake in Extrovis AG for $15 million. This marks a significant step in the company's strategy to focus exclusively on the aerospace and defence (A&D) sector by divesting non-core assets.

Financial Boost and Expansion

The $15 million from the sale provides Sigma with greater financial flexibility for its A&D expansion plans. This capital is already being used, notably in acquiring AS Strategic, a defence and space firm with European links. The company also recently secured new contracts worth approximately ₹100 crore from the Ministry of Defence and public sector units. This focus on its core business has been welcomed by the market. Sigma's stock was trading around ₹216.19 on April 22, 2026, showing strong year-on-year gains. Its market capitalization is currently estimated between ₹34 billion and ₹36 billion INR.

India's Growing Defence Market

This strategic shift aligns with India's rapidly growing aerospace and defence industry. The sector is expected to grow at a CAGR of 7.10% to 7.5% until 2034, potentially reaching over $56 billion USD. This growth is driven by increased defence spending and government support for local manufacturing through initiatives like 'Make in India'. Sigma is well-positioned to benefit from this trend, particularly as the market increasingly adopts advanced technologies. The company's P/E ratio is between 23.16 and 27.9. Over the past year, Sigma's stock returns have ranged from approximately 221% to 237%, indicating strong investor confidence in its new direction.

Analyst Concerns and Risks

However, some analysts highlight significant risks. MarketsMojo rated Sigma Advanced Systems Ltd. as a 'Sell' on February 16, 2026. The rating cited weak long-term financial strength, a steep -280.80% CAGR in operating profits over the last five years, and insufficient earnings to cover interest costs. This has resulted in a negative return on capital employed. The company also faces uncertainties, including a pending amalgamation scheme with Megasoft Limited, awaiting approval from the National Company Law Tribunal. India Ratings has placed the company on 'Rating Watch with Developing Implications'. While government contracts are key in the defence sector, they can also mean long sales cycles and unpredictable budgets. Questions also remain about Sigma's R&D capabilities and long-term competitive edge, given its past IT and pharmaceutical focus and a history of assembling rather than inventing technologies in some areas.

Future Outlook

Sigma's decision to focus on aerospace and defence places it in a sector with strong long-term growth potential, supported by national security needs and government backing for local production. Recent acquisitions and orders suggest immediate progress. However, future success depends on Sigma's ability to manage operations effectively, control working capital, and address the core financial concerns raised by analysts. While the defence industry outlook is positive, Sigma's capability to convert this growth into sustained, profitable expansion remains a key focus for investors.